BLOG

FDA Authorizes Florida’s Drug Importation Program

FDA Authorizes Florida’s Drug Importation Program

Jan 9, 2024

FDA Authorizes Florida’s Drug Importation Program | by: Deneen Fumich, RPh | Article Posted: January 9, 2024 | The U.S. Food and Drug Administration approves the first state request to import drugs from Canada. Announced on January 5th, the FDA has authorized...

Wholesale Distributor & Reverse Distributor

FDA Proposed Rules Review, Part 1 of 4: An Introduction

FDA Proposed Rules Review, Part 1 of 4: An Introduction

Feb 10, 2022

FDA Proposed Rules Review, Part 1 of 4: An Introduction Written-by: Sumeet Singh, CEO This article will review the FDA’s proposed rule concerning...

Top SOM Insights from 2021

Top SOM Insights from 2021

Nov 18, 2021

Top SOM Insights from 2021 The continuous development and sophistication of NavigateSOM, along with helping clients meet their objectives, pushes...

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023

FDA Authorizes Florida’s Drug Importation Program

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2024/01/Blog-Featured-Images-1600x880-3-100x55.png" alt="FDA Authorizes Florida’s Drug Importation Program" itemprop="image" class="left" />

FDA Authorizes Florida’s Drug Importation Program

January 9, 2024January 10, 2024

FDA Warning on Xylazine: Mitigating Human Risk

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-25-100x55.png" alt="FDA Warning on Xylazine: Mitigating Human Risk" itemprop="image" class="left" />

FDA Warning on Xylazine: Mitigating Human Risk

November 6, 2023November 6, 2023

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

<img decoding="async" src="https://pharma.solutions/wp-content/uploads/2023/11/Blog-Featured-Images-1600x880-24-100x55.png" alt="Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know " itemprop="image" class="left" />

Minnesota’s New Prescription Drug Price Transparency Reporting: What You Need to Know

November 6, 2023